Skip to content

Galen™ Second Read™

by Ibex Medical Analytics Ltd

510(k) K241232

Galen Second Read is a medical device (FDA Class II; FDA product code QPN, Software Algorithm Device To Assist Users In Digital Pathology) made by Ibex Medical Analytics Ltd, cleared under FDA 510(k) K241232 on 24 Jan 2025, active as of 25 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 25 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK241232 Date24 Jan 2025ClearedStatusActive

Official records

From the FDA record

Received by the FDA
2 May 2024
FDA decision
24 Jan 2025 (Substantially Equivalent)
FDA review time
267 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K241232 (openFDA), as read on 25 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QPN
FDA applicant
Ibex Medical Analytics , Ltd.
Device class
Class II
Regulation
21 CFR Part 864.3750
Advisory committee
Pathology
FDA decision
SESE Substantially Equivalent

Devices cleared under K241232

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K241232
UDI-DISize and differences
Ibex Prostate Detect 3.1-US
IBEX MEDICAL ANALYTICS LTD
3.1-US07290019124016 —On the market

Other devices from Ibex Medical Analytics Ltd

See all devices from Ibex Medical Analytics Ltd →